Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Glioblastoma × Neurosurgical Procedures × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Temozolomide 107 Radiotherapy 60 Radiation 28 Bevacizumab 18 Nivolumab 15 Magnetic Resonance Spectroscopy 15 Surgical Procedures, Operative 12 Irinotecan 11 Cyclophosphamide 9 Chemotherapy, Adjuvant 9 Specimen Handling 8 Radiotherapy, Intensity-Modulated 8 Radiosurgery 8 O(6)-benzylguanine 8 Carmustine 8 poly ICLC 7 pembrolizumab 7 motexafin gadolinium 7 Flucytosine 7 sargramostim 6 Radiotherapy, Conformal 6 Leukapheresis 6 Erlotinib Hydrochloride 6 fludarabine 5 Lomustine 5 Ipilimumab 5 Imiquimod 5 Imatinib Mesylate 5 Hydroxyurea 5 Granulocyte-Macrophage Colony-Stimulating Factor 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06097975 2025-01-20

NEO-GLITIPNI

Universitair Ziekenhuis Brussel

Phase 1 Recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡